CRISPR-iPAS: a novel dCAS13-based method for alternative polyadenylation interference S Tian, B Zhang, Y He, Z Sun, J Li, Y Li, H Yi, Y Zhao, X Zou, Y Li, H Cui, ... Nucleic Acids Research 50 (5), e26-e26, 2022 | 17 | 2022 |
A cross-tissue investigation of molecular targets and physiological functions of Nsun6 using knockout mice W Wang, H Huang, H Jiang, C Tian, Y Tang, D Gan, X Wen, Z Song, Y He, ... International Journal of Molecular Sciences 23 (12), 6584, 2022 | 10 | 2022 |
RUNX proteins as epigenetic modulators in cancer H Yi, Y He, Q Zhu, L Fang Cells 11 (22), 3687, 2022 | 9 | 2022 |
Pooled CRISPR Screening Identifies P-Bodies as Repressors of Cancer Epithelial–Mesenchymal Transition L Fang, L Zhang, M Wang, Y He, J Yang, Z Huang, Y Tan, K Fang, J Li, ... Cancer Research 84 (5), 659-674, 2024 | 5 | 2024 |
Pan‐tissue analysis of allelic alternative polyadenylation suggests widespread functional regulation Y Li, B Schaefke, X Zou, M Zhang, F Heyd, W Sun, B Zhang, G Li, W Liang, ... Molecular systems biology 16 (4), e9367, 2020 | 5 | 2020 |